In April 2026, Abridge raised $300 million in a Series E round led by Andreessen Horowitz and Khosla Ventures, valuing the ambient artificial intelligence (AI) scribe company at $5.3 billion.[1] The same window saw five competing AI scribe companies raise over $25 million each: Ambience Healthcare ($243 million Series C), Commure ($200 million), Heidi Health ($65 million at a $465 million valuation), Nabla ($70 million Series C), and Hyro ($45 million growth round).[1][2][3]
When this much capital flows into a single product category in twelve months, it tells you this has gone from a nascent investment to a fairly large AI category
What An AI Scribe Actually Does
An ambient AI scribe is software that listens to a clinical encounter in real time and produces a structured note ready to drop into the patient's chart. The clinician wears a microphone or has a phone or tablet in the room. The patient consents. The software transcribes, applies natural language processing, and outputs a note in the format the electronic health record (EHR) expects.
The clinician reviews and signs. Documentation that used to take 60 to 90 minutes per day, often spilling into evenings, can drop to a fraction of that. Vendor data and early academic studies suggest 60 percent or more of physicians using ambient scribes report reduced burnout.[4] Adoption inside health systems has been faster than almost any other clinical technology in the past decade.
The why is simple. American physicians spend two hours on documentation for every hour of patient care. The math is unsustainable, and AI scribes are the first credible relief in twenty years.
The 2026 AI Scribe Market
Six companies dominate the funded landscape. Each takes a different position on price, deployment, and EHR fit.
Abridge raised $300 million Series E at a $5.3 billion valuation.[1] It is now embedded in Athenahealth's community-practice tier with clinical decision support powered by Wolters Kluwer's UpToDate.[1] Abridge is the safe institutional choice for groups of ten or more physicians. Pricing is enterprise-tier.
Ambience Healthcare raised $243 million Series C led by Oak HC/FT.[3] Deployed across multiple Epic-integrated health systems, with published return-on-investment data. Built for hospital-scale buyers.
Suki AI has raised approximately $168 million total. The most accessible option for smaller practices, with per-provider pricing and integrations into Athenahealth, MEDITECH, and other major EHRs.
Heidi Health raised $65 million at a $465 million valuation.[2] Australia-headquartered, expanding globally. The strongest budget-tier option for solo and two-physician offices.
Nabla raised $70 million Series C led by HV Capital, simultaneously expanding into agentic AI and launching support for 31 new languages.[1] Multilingual capability is its competitive moat.
Hippocratic AI is the category outlier. Rather than transcribing visits, it is building voice AI agents for patient intake and inpatient nursing support.[1] Worth tracking, not buying yet.
The pattern is clear. There is a tier for hospital systems, a tier for mid-market group practices, and a tier for small independent offices. The product gap between them is closing fast.
What The $5.3 Billion Valuation Signals
A $5.3 billion valuation in healthcare AI is not a vanity number. To justify it, Abridge has to grow into roughly $300 to $500 million in annual recurring revenue within three to five years. That requires deep penetration into the market the company is currently building from: hospital systems and large multi-specialty groups.
That penetration depends on three things, and the pattern matters for any practice deciding when to buy.
First, the integration moat. Abridge's Athenahealth distribution deal puts it inside the EHR many independent practices already use. Once an EHR vendor selects a default ambient scribe partner, switching costs go up for everyone in that ecosystem. Other scribes can still sell into Athena practices, but the activation friction tilts toward the embedded option.
Second, the data moat. Every clinical conversation an AI scribe captures becomes training data for the next version. The companies with the most deployments build models that produce better notes faster, which closes more deals, which produces more deployments. This is the standard machine learning flywheel, and it favors whoever scales first.
Third, the policy moat. AI scribes that can document for billing compliance, surface coding suggestions, and integrate with revenue cycle management tools become more than scribes. Abridge's stated plan to embed revenue-cycle AI earlier in the clinical conversation[1] is the move from documentation tool to billing infrastructure. Once a practice's billing depends on the scribe, the scribe is sticky.
These three moats are why investors treat the category as infrastructure rather than software.
Where This Lands for Small and Independent Practices
The story so far is about hospital systems and large groups. The more interesting question is what happens to the long tail.
Roughly one in three primary care physicians in the United States now practices in a small or independent office, including concierge medicine and direct primary care (DPC).[5] These practices share two structural traits that make AI scribes a different kind of decision than they are for hospitals.
The first trait is time use. A traditional fee-for-service primary care physician carries a panel of 2,000 to 2,500 patients[5] and a documentation burden driven mostly by billing. For these doctors, AI scribes are about catching up: keeping the practice viable inside an unsustainable workload. A concierge physician carries a panel under 300 patients with longer visits, and a DPC physician sits in between with panels up to about 800. For these practices, documentation is not the dominant cost. It is the dominant tax on the evenings and weekends physicians left big systems to reclaim.
The second trait is buying power. Independent practices cannot sign hospital-tier contracts and do not need hospital-tier features. Many practices fit on a per-provider monthly price somewhere between $200 and $500. For perspective, that is roughly comparable to what a single patient pays for a mid-priced DPC subscription, and a small fraction of monthly revenue per concierge member. The funded vendors below the very top of the market, including Suki, Heidi, Nabla, and Hyro, are all aimed at this tier.
Priority Physicians, a four-physician concierge practice in the Indianapolis metro, is roughly the size where the buying decision changes character. Four physicians do not need a 100-seat enterprise contract. They cannot afford to lose seven hours a week each to charting either. The right scribe is one designed for their tier, not one repackaged for it.
Five Questions To Ask Any Vendor
Before signing with any AI scribe company, the same questions apply whether you are running a hospital department or a two-physician office.
Does the scribe integrate natively with your EHR, with a working demo of your specific configuration? Ask for a live test patient before you sign, not after.
What is the per-provider monthly price including all required add-ons? Insist on a flat rate per physician. Avoid contracts priced as a percentage of practice revenue.
Who owns the audio recordings and the resulting notes? The contract should state the practice owns all data and that the vendor cannot use patient audio to train future models without explicit written consent.
How easy is it to export your notes if you cancel? Confirm a standard export format works without paid services or vendor lock-in.
How gracefully does pricing scale up and down with headcount? Solo practices that may grow, and groups that may consolidate, both need flexibility.
The contract terms matter as much as the technology in 2026. The product is moving fast enough that twelve-month terms with a sixty-day exit are reasonable. Three-year terms in this category are not.
A Closing Thought On Time
The most useful thing the funding round confirms is that physician time is finally being priced like the scarce asset it is. AI scribes do not just speed up charting. They restore an hour or two of evenings every day, the kind of time that drove many physicians into concierge medicine and DPC in the first place.
The right way to spend that time depends on the practice. Some physicians will see slightly more patients. Some will go home earlier. Some will let visits run longer because the encounter no longer ends with thirty minutes of after-hours typing. None of those choices are wrong, but the technology should not be allowed to quietly compress visit length without an intentional decision. The relationship is the product.
NextMD lists physician-led concierge and DPC practices for patients searching nationwide. Practices that recover physician time using AI scribes are precisely the practices that grow their panels and add locations, and our tools are built around how those practices actually work.
Sources
Pearl, R. (2026). Abridge scores $300M Series E, boosting valuation to $5.3B. Fierce Healthcare. https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla
Heidi Health raises $65M to expand global reach of its AI medical scribe platform. (2026). MobiHealthNews. https://www.mobihealthnews.com/news/heidi-health-raises-65m-expand-global-reach-its-ai-medical-scribe-platform
Oak HC/FT. (2025). Ambience Healthcare Announces $243 Million Series C to Scale its AI Platform for Health Systems. https://www.oakhcft.com/news/ambience-healthcare-announces-243-million-series-c-to-scale-its-ai-platform-for-health-systems
Phyx Primary Care. (2026). Ambient scribes decrease burnout 60% among small primary care providers. Cited in Fierce Healthcare. https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-scribes-decrease-burnout-60-small-primary-care-providers-phyx
Milbank Memorial Fund. (2026). The Health of US Primary Care: 2026 Scorecard. https://www.milbank.org/publications/the-health-of-us-primary-care-2026-scorecard/